sponsored byAAAS Golden Fund

EurekAlert from AAAS
Home About us
Advanced Search
10-Feb-2010 03:32
Eastern US Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia Gallery

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Portal: Disease in the Developing World

Portal Home

AIDS, SARS, influenza, West Nile fever, cholera, tuberculosis, ebola -- these diseases represent only some of the threats to public health that have exploded over the past decades.
MORE...

 

Current News Releases

Tulane receives $15 million NIH contract to develop vaccine and treatment for deadly fever Tulane receives $15 million NIH contract to develop vaccine and treatment for deadly fever

Tulane receives $15 million NIH contract to develop vaccine and treatment for deadly fever

Barcelona becomes part of a worldwide research on tuberculosis Barcelona becomes part of a worldwide research on tuberculosis

Barcelona becomes part of a worldwide research on tuberculosis

Antiretroviral therapy associated with increase in pregnancy in sub-Saharan Africa Antiretroviral therapy associated with increase in pregnancy in sub-Saharan Africa

Antiretroviral therapy associated with increase in pregnancy in sub-Saharan Africa

One-third of antimalarial medicines sampled in 3 African nations found to be substandard One-third of antimalarial medicines sampled in 3 African nations found to be substandard

One-third of antimalarial medicines sampled in 3 African nations found to be substandard

Scripps research team reveals how an old drug could have a new use for treating river blindness Scripps research team reveals how an old drug could have a new use for treating river blindness

Scripps research team reveals how an old drug could have a new use for treating river blindness

UC Riverside licenses technology to OlFactor Laboratories, Inc. UC Riverside licenses technology to OlFactor Laboratories, Inc.

UC Riverside licenses technology to OlFactor Laboratories, Inc.

NTU researchers complete the world's first in-depth study of the malaria parasite genome NTU researchers complete the world's first in-depth study of the malaria parasite genome

NTU researchers complete the world's first in-depth study of the malaria parasite genome

Yale-developed test can help predict and diagnose preeclampsia Yale-developed test can help predict and diagnose preeclampsia

Yale-developed test can help predict and diagnose preeclampsia

MORE RELEASES

 

 

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources